What patients with pulmonary fibrosis and their partners think: A live, educative survey in the Netherlands and Germany

ERJ Open Research

Volumn 3, Issue 1, 2017, Pages

  van Manen, Mirjam J G ^a   Kreuter, Michael ^b,c   van den Blink, Bernt ^a   Oltmanns, Ute ^b,c   Palmowski, Karin ^b,c   Brunnemer, Eva ^b,c   Hummler, Simone ^b   Tak, Nelleke C ^a   van den Toorn, Leon ^a   Miedema, Jelle ^a   Hoogsteden, Henk C ^a   Wijsenbeek, Marlies S ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Member of the German Center for Lung Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; CLINICAL TRIAL; COPING BEHAVIOR; CULTURAL FACTOR; DISEASE COURSE; GERMANY; HEALTH STATUS; HEALTH SURVEY; HOSPITAL; HUMAN; KNOWLEDGE; LEARNING; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; NURSE SPECIALIST; PATIENT CARE; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 85114078151     PISSN: None     EISSN: 23120541     Source Type: Journal    
DOI: 10.1183/23120541.00065-2016     Document Type: Article

References (36)

1. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
2. Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA). The Voice of the Patient; A series of reports from the U.S. Food and Drug Administration’s (FDA’s) Patient-Focused Drug Development Initiative. Idiopathic Pulmonary Fibrosis. March 2015. www.fda.gov/downloads/ForIndustry/ UserFees/PrescriptionDrugUserFee/UCM440829.pdf Date last updated: March 2015.
3. Schoenheit G, Becattelli I, Cohen AH. Living with idiopathic pulmonary fibrosis: an in-depth qualitative survey of European patients. Chron Respir Dis 2011; 8: 225-231.
4. Bajwah S, Higginson IJ, Ross JR, et al. The palliative care needs for fibrotic interstitial lung disease: a qualitative study of patients, informal caregivers and health professionals. Palliat Med 2013; 27: 869-876.
5. Overgaard D, Kaldan G, Marsaa K, et al. The lived experience with idiopathic pulmonary fibrosis: a qualitative study. Eur Respir J 2016; 47: 1472-1480.
6. Sampson C, Gill BH, Harrison NK, et al. The care needs of patients with idiopathic pulmonary fibrosis and their carers (CaNoPy): results of a qualitative study. BMC Pulm Med 2015; 15: 155.
7. Duck A, Spencer LG, Bailey S, et al. Perceptions, experiences and needs of patients with idiopathic pulmonary fibrosis. J Adv Nurs 2015; 71: 1055-1065.
8. Thickett DR, Kendall C, Spencer LG, et al. Improving care for patients with idiopathic pulmonary fibrosis (IPF) in the UK: a round table discussion. Thorax 2014; 69: 1136-1140.
9. Bonella F, Wijsenbeek M, Molina-Molina M, et al. European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers. Eur Respir J 2016; 47: 597-606.
10. Yount SE, Beaumont JL, Chen SY, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. Lung 2016; 194: 227-234.
11. Fisher JH, O’Connor D, Flexman AM, et al. Accuracy and reliability of internet resources for information on idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2016; 194: 218-225.
12. Russell AM, Ripamonti E, Vancheri C. Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients’ perspectives of the disease and treatment. BMC Pulm Med 2016; 16: 10.
13. Donker T, van Straten A, Marks I, et al. Quick and easy self-rating of Generalized Anxiety Disorder: validity of the Dutch web-based GAD-7, GAD-2 and GAD-SI. Psychiatry Res 2011; 188: 58-64.
14. Kreuter M, Ehlers-Tenenbaum S, Palmowski K, et al. Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis. PLoS One 2016; 11: e0151425.
15. Behr J, Kreuter M, Hoeper MM, et al. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur Respir J 2015; 46: 186-196.
16. Janssen DJ, Wouters EF, Spruit MA. Psychosocial consequences of living with breathlessness due to advanced disease. Curr Opin Support Palliat Care 2015; 9: 232-237.
17. Belkin A, Albright K, Swigris JJ. A qualitative study of informal caregivers’ perspectives on the effects of idiopathic pulmonary fibrosis. BMJ Open Respir Res 2014; 1: e000007.
18. Janssen DJ, Spruit MA, Uszko-Lencer NH, et al. Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Med 2011; 14: 735-743.
19. Jácome C, Figueiredo D, Gabriel R, et al. Predicting anxiety and depression among family carers of people with chronic obstructive pulmonary disease. Int Psychogeriatr 2014; 26: 1191-1199.
20. Frei A, Muggensturm P, Putcha N, et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol 2014; 67: 904-911.
21. Vermeulen KM, Bosma OH, Bij W, et al. Stress, psychological distress, and coping in patients on the waiting list for lung transplantation: an exploratory study. Transpl Int 2005; 18: 954-959.
22. Wuyts WA, Peccatori FA, Russell AM. Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models. Eur Respir Rev 2014; 23: 231-238.
23. National Institute for Health and Care Excellence (NICE). Diagnosis and Management of Suspected Idiopathic Pulmonary Fibrosis. www.nice.org.uk/guidance/cg163/evidence/full-guideline-190086877 Date last updated: June 2013.
24. Bridges JF, Paly VF, Barker E, et al. Identifying the benefits and risks of emerging treatments for idiopathic pulmonary fibrosis: a qualitative study. Patient 2015; 8: 85-92.
25. Bajwah S, Koffman J, Higginson IJ, et al. ‘I wish I knew more …' the end-of-life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and health professionals. BMJ Support Palliat Care 2013; 3: 84-90.
26. Lanken PN, Terry PB, Delisser HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 2008; 177: 912-927.
27. Lindell KO, Olshansky E, Song MK, et al. Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners. Heart Lung 2010; 39: 304-313.
28. Collard HR, Tino G, Noble PW, et al. Patient experiences with pulmonary fibrosis. Respir Med 2007; 101: 1350-1354.
29. Duck A, Pigram L, Errhalt P, et al. IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in Europe. Adv Ther 2015; 32: 87-107.
30. Wenz HJ, Zupanic M, Klosa K, et al. Using an audience response system to improve learning success in practical skills training courses in dental studies - a randomised, controlled cross-over study. Eur J Dent Educ 2014; 18: 147-153.
31. Uhari M, Renko M, Soini H. Experiences of using an interactive audience response system in lectures. BMC Med Educ 2003; 3: 12.
32. Datta R, Datta K, Venkatesh MD. Evaluation of interactive teaching for undergraduate medical students using a classroom interactive response system in India. Med J Armed Forces India 2015; 71: 239-245.
33. British Lung Foundation. Lost in the System. IPF: the Patient Experience in England. www.blf.org.uk/sites/default/files/ BLF-IPF-Report-2015-Lost-in-the-System-250215.pdf Date last accessed: February 23, 2016. Date last updated: 2015.
34. Shen J, Buechler A, Byrne J, et al. Clinical Research Participation as a Care Option. www.quintiles.com/library/ white-papers/clinical-research-participation-as-a-care-option Date last accessed: February 24, 2016. Date last updated: October 28, 2015.
35. Patient-Centered Outcomes Research Institute. About us. www.pcori.org/about-us Date last accessed: April 1, 2016. Date last updated: October 6, 2014.
36. Wijsenbeek M, Bendstrup E, Ross J, et al. Cultural differences in palliative care in patients with idiopathic pulmonary fibrosis. Chest 2015; 148: e56.